SIGNAL AND PROPEPTIDE PROCESSING OF HUMAN TISSUE PLASMINOGEN-ACTIVATOR - ACTIVITY OF A PRO-TPA DERIVATIVE

被引:16
作者
BERG, DT
GRINNELL, BW
机构
[1] Cardiovascular Research, Lilly Research Laboratories Lilly Corporate Center, Indianapolis
关键词
D O I
10.1016/0006-291X(91)91713-M
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have explored the heterogeneity in the proteolytic processing of the N-terminus of human tissue plasminogen activator. We demonstrate that normal propeptide processing occurs following Arg-4, preceding the sequence Gly-Ala-Arg-Ser+1. Generation of the previously designated Ser+1 occurs via secondary proteolysis following secretion. By site-directed mutagenesis, we have eliminated this cleavage site resulting in a derivative containing the propeptide sequence. N-terminal sequence analysis of this form indicated that signal peptide cleavage occurs following Ser-13. The pro-tPA derivative had near normal serine protease and plasminogen activating activities, and could be stimulated by fibrin. An additional derivative, containing the tribasic sequence from the human protein C propeptide preceding Ser+1, was secreted with full processing of the propeptide. Our data have defined the cleavages for the signal peptide and propeptide and demonstrate that a tribasic sequence can be used to eliminate N-terminal heterogeneity in this molecule. In addition, we demonstrate that, unlike several other serine proteases, a propeptide sequence does not alter the activity of this enzyme. © 1991.
引用
收藏
页码:1289 / 1296
页数:8
相关论文
共 21 条
[1]   PREDICTED SECONDARY STRUCTURES OF AMINO-TERMINAL EXTENSION SEQUENCES OF SECRETED PROTEINS [J].
AUSTEN, BM .
FEBS LETTERS, 1979, 103 (02) :308-313
[2]  
BANG NU, 1989, ANNU REV PHARMACOL, V29, P323
[3]   DEFECTIVE PROPEPTIDE PROCESSING OF BLOOD-CLOTTING FACTOR-IX CAUSED BY MUTATION OF ARGININE TO GLUTAMINE AT POSITION -4 [J].
BENTLEY, AK ;
REES, DJG ;
RIZZA, C ;
BROWNLEE, GG .
CELL, 1986, 45 (03) :343-348
[4]   A VARIANT ENHANCER REGULATORY REGION FROM A CLONED HUMAN PROTOTYPE BK-VIRUS GENOME [J].
BERG, DT ;
WALLS, JD ;
GRINNELL, BW .
NUCLEIC ACIDS RESEARCH, 1988, 16 (18) :9057-9057
[5]  
BURCK PJ, 1990, J BIOL CHEM, V265, P5170
[6]   TISSUE-TYPE PLASMINOGEN-ACTIVATOR - A REVIEW OF ITS PHARMACOLOGY AND THERAPEUTIC USE AS A THROMBOLYTIC AGENT [J].
COLLEN, D ;
LIJNEN, HR ;
TODD, PA ;
GOA, KL .
DRUGS, 1989, 38 (03) :346-388
[7]  
FISHER JM, 1988, J BIOL CHEM, V263, P16515
[8]   ENDOPROTEOLYTIC PROCESSING OF THE HUMAN PROTEIN-C PRECURSOR BY THE YEAST KEX2 ENDOPEPTIDASE COEXPRESSED IN MAMMALIAN-CELLS [J].
FOSTER, DC ;
HOLLY, RD ;
SPRECHER, CA ;
WALKER, KM ;
KUMAR, AA .
BIOCHEMISTRY, 1991, 30 (02) :367-372
[9]   ENDOPROTEOLYTIC PROCESSING OF THE DIBASIC CLEAVAGE SITE IN THE HUMAN PROTEIN-C PRECURSOR IN TRANSFECTED MAMMALIAN-CELLS - EFFECTS OF SEQUENCE ALTERATIONS ON EFFICIENCY OF CLEAVAGE [J].
FOSTER, DC ;
SPRECHER, CA ;
HOLLY, RD ;
GAMBEE, JE ;
WALKER, KM ;
KUMAR, AA .
BIOCHEMISTRY, 1990, 29 (02) :347-354
[10]   SIGNAL SEQUENCES [J].
GIERASCH, LM .
BIOCHEMISTRY, 1989, 28 (03) :923-930